We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Shares of IQVIA Holdings Inc. (IQV - Free Report) scaled a 52-week high of $240.82 in the trading session on May 21, before closing a tad lower at $238.96.
The company’s shares have charted a solid trajectory, appreciating 33.4% year to date, ahead of 1.8% decline of the industry it belongs to and 11.2% rally of the Zacks S&P 500 composite.
Notably, IQVIA has witnessed a 5.8% rise in share price since it posted first-quarter 2021 results.
Let’s find out what’s supporting the uptick.
Upbeat 2021 Guidance
IQVIA raised its 2021 guidance. Revenues are now expected within $13.2-$13.5 billion compared with the prior guidance of $12.55-$12.90 billion. The current Zacks Consensus Estimate of $13.24 billion lies within the updated guidance.
Adjusted earnings per share are now expected to be between $8.50 and $8.75, compared with the prior guidance of $7.89-$8.20. The current Zacks Consensus Estimate of $8.49 lies below the updated guidance.
Adjusted EBITDA is now anticipated to be between $2.900 billion and $2.965 billion compared with the prior guidance of $2.760-$2.840 billion.
Consecutive Earnings & Revenue Beat
IQVIA Holdings came up with better-than-expected earnings and revenue performance in all four quarters of 2020 as well as in first-quarter 2021. The company’s bottom line continued to benefit from improvement in operational efficiency and decline in interest expenses. Strength across the company’s Technology & Analytics Solutions segment boosts the top line.
Robust Set of Capabilities
IQVIA has a strong healthcare-specific global IT infrastructure, analytics-driven clinical development capabilities, a robust real-world solutions ecosystem and a growing set of proprietary clinical and commercial applications that allow it to grow and retain relationships with healthcare stakeholders. The company’s combined offerings of research and development, and commercial services have been helping it to develop trusted relationships, resulting in a diversified base of over 10,000 clients in over 100 countries.
The long-term expected earnings per share (three to five years) growth rate for Equifax, Charles River and TransUnion is 14%, 15.5% and 20.9%, respectively.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Image: Shutterstock
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
Shares of IQVIA Holdings Inc. (IQV - Free Report) scaled a 52-week high of $240.82 in the trading session on May 21, before closing a tad lower at $238.96.
The company’s shares have charted a solid trajectory, appreciating 33.4% year to date, ahead of 1.8% decline of the industry it belongs to and 11.2% rally of the Zacks S&P 500 composite.
Notably, IQVIA has witnessed a 5.8% rise in share price since it posted first-quarter 2021 results.
Let’s find out what’s supporting the uptick.
Upbeat 2021 Guidance
IQVIA raised its 2021 guidance. Revenues are now expected within $13.2-$13.5 billion compared with the prior guidance of $12.55-$12.90 billion. The current Zacks Consensus Estimate of $13.24 billion lies within the updated guidance.
Adjusted earnings per share are now expected to be between $8.50 and $8.75, compared with the prior guidance of $7.89-$8.20. The current Zacks Consensus Estimate of $8.49 lies below the updated guidance.
Adjusted EBITDA is now anticipated to be between $2.900 billion and $2.965 billion compared with the prior guidance of $2.760-$2.840 billion.
Consecutive Earnings & Revenue Beat
IQVIA Holdings came up with better-than-expected earnings and revenue performance in all four quarters of 2020 as well as in first-quarter 2021. The company’s bottom line continued to benefit from improvement in operational efficiency and decline in interest expenses. Strength across the company’s Technology & Analytics Solutions segment boosts the top line.
Robust Set of Capabilities
IQVIA has a strong healthcare-specific global IT infrastructure, analytics-driven clinical development capabilities, a robust real-world solutions ecosystem and a growing set of proprietary clinical and commercial applications that allow it to grow and retain relationships with healthcare stakeholders. The company’s combined offerings of research and development, and commercial services have been helping it to develop trusted relationships, resulting in a diversified base of over 10,000 clients in over 100 countries.
Zacks Rank and Other Stocks to Consider
IQVIA Holdings currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some other top-ranked stocks in the broader Zacks Business Services sector are Equifax (EFX - Free Report) , Charles River (CRAI - Free Report) and TransUnion (TRU - Free Report) , each carrying a Zacks Rank #2.
The long-term expected earnings per share (three to five years) growth rate for Equifax, Charles River and TransUnion is 14%, 15.5% and 20.9%, respectively.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>